BioMarin Pharmaceutical Inc. (BMRN), on Tuesday, announced the appointment of Ian Clark as Chair of the Board, subject to his election at the company's Annual Meeting on June 2.
Clark will take over from current Chair Richard Meier, with the appointment becoming effective immediately following the Annual Meeting.
Clark joined the company's board in 2025 and brings extensive experience in the biopharmaceutical industry, including serving as Chief Executive Officer of Genentech from 2010 to 2016.
Meier will retire after nearly two decades on the board, having joined in 2006 and serving as Chair since 2023.
BioMarin Pharmaceutical closed trading 0.47% lesser at $54.62 on the Nasdaq. In the after-hours, the stock traded 1.24% at $55.30, 0.68 cents up.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.